Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion?-Reference-Cited by-同舟云学术

Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion?

Published:2023-03-27 Issue:1 Volume:408 Page:
ISSN:1435-2451
Container-title:Langenbeck's Archives of Surgery
language:en
Short-container-title:Langenbecks Arch Surg

Author:

Zenger Serkan^ORCID,Gurbuz Bulent^ORCID,Can Ugur^ORCID,Erginoz Ergin^ORCID,Ozata Ibrahim Halil^ORCID,Yilmaz Serpil Postgil,Taskin Orhun Cıg^ORCID,Peker Onder,Adsay Volkan^ORCID,Balik Emre^ORCID,Bugra Dursun^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00423-023-02864-x.pdf

Reference37 articles.

1. Bilchik AJ, Nora DT, Saha S et al (2002) The use of molecular profiling of early colorectal cancer to predict micrometastases. Arch Surg 137:1377–1383. https://doi.org/10.1001/archsurg.137.12.1377

2. Watanabe T, Muro K, Ajioka Y et al (2018) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol 23:1–34. https://doi.org/10.1007/s10147-017-1101-6

3. Horcic M, Koelzer VH, Karamitopoulou E, Terracciano L, Puppa G, Zlobec I, Lugli A (2013) Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. Hum Pathol 44:697–705. https://doi.org/10.1016/j.humpath.2012.07.026

4. Sobrero A (2006) Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? For the proposal. Lancet Oncol 7:515–516. https://doi.org/10.1016/S1470-2045(06)70727-6

5. Figueredo A, Coombes ME, Mukherjee S (2008) Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev:CD005390. https://doi.org/10.1002/14651858.CD005390.pub2